United States · Business magazines · Institutional Investor

Biopharma’s Sickly September

Published by Institutional Investor · United States 5 d ago

September was a rough month for prominent biopharma and life sciences hedge funds.Many lost money, some by double-digit percentage rates. As a result, quite a few funds are up…

Read the full article on Institutional Investor Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.institutionalinvestor.com)

Also worth reading

Inc.

Think Being a Night Owl Is Just a Sleep Preference? Researchers Link It to a Depression Subtype

Markets Insider (Business Insider)

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Fervo Energy Company Investors to Inquire About Securities Class Action Investigation - FRVO

Kiplinger

Biopharma’s Sickly September

Share

Also worth reading

Think Being a Night Owl Is Just a Sleep Preference? Researchers Link It to a Depression Subtype

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Fervo Energy Company Investors to Inquire About Securities Class Action Investigation - FRVO

Can a Roth Conversion Wait if You're 5-10 Years From Retiring?

Look up tonight: October’s full moon is for hunters

Millennials are having their midlife career crisis

Carson Hocevar Is Telling NASCAR Fans To Vote For Somebody Else